Reshema Kemps-Polanco - Feb 1, 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/Matthew Daniel as attornery-in-fact for Reshema Kemps-Polanco
Stock symbol
CRL
Transactions as of
Feb 1, 2024
Transactions value $
$87,596
Form type
4
Date filed
2/5/2024, 08:31 PM
Previous filing
Jan 30, 2024
Next filing
May 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +170 $0.00 170 Feb 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $87.6K +399 $219.54 399 Feb 1, 2024 Common Stock 399 $219.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 170 unvested restricted stock units that vest on 5/7/2024.
F2 The stock options become exercisable 5/7/2024.